Related Experiment Video
Updated: Feb 12, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Identification of Epithelial-Mesenchymal Transition-related Target Genes Induced by the Mutation of Smad3 Linker
Sujin Park1, Kyung-Min Yang1, Yuna Park1,2
1Precision Medicine Research Center, Advanced Institutes of Convergence Technology, Suwon, Korea.
Background:
Smad3 linker phosphorylation plays essential roles in tumor progression and metastasis. We have previously reported that the mutation of Smad3 linker phosphorylation sites (Smad3-Erk/Pro-directed kinase site mutant constructs [EPSM]) markedly reduced the tumor progression while increasing the lung metastasis in breast cancer.
Methods:
We performed high-throughput RNA-Sequencing of the human prostate cancer cell lines infected with adenoviral Smad3-EPSM to identify the genes regulated by Smad3-EPSM.
Results:
In this study, we identified genes which are differentially regulated in the presence of Smad3-EPSM. We first confirmed that Smad3-EPSM strongly enhanced a capability of cell motility and invasiveness as well as the expression of epithelial-mesenchymal transition marker genes, CDH2, SNAI1, and ZEB1 in response to TGF-β1 in human pancreatic and prostate cancer cell lines. We identified GADD45B, CTGF, and JUNB genes in the expression profiles associated with cell motility and invasiveness induced by the Smad3-EPSM.
Conclusions:
These results suggested that inhibition of Smad3 linker phosphorylation may enhance cell motility and invasiveness by inducing expression of GADD45B, CTGF, and JUNB genes in various cancers.
Insights
Inhibiting Smad3 linker phosphorylation (Smad3-EPSM) enhances cancer cell motility and invasiveness. This study identifies GADD45B, CTGF, and JUNB as key genes involved in this process, offering potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metastasis
Background:
- Smad3 linker phosphorylation is crucial for tumor progression and metastasis.
- Previous work showed Smad3-EPSM mutation reduced tumor progression but increased lung metastasis in breast cancer.
Purpose of the Study:
- To identify genes regulated by Smad3-EPSM using RNA-Sequencing.
- To understand the role of Smad3 linker phosphorylation in cancer cell behavior.
Main Methods:
- High-throughput RNA-Sequencing was performed on human prostate cancer cell lines infected with adenoviral Smad3-EPSM.
- Gene expression profiles were analyzed in response to Smad3-EPSM.
Main Results:
- Smad3-EPSM enhanced cell motility, invasiveness, and epithelial-mesenchymal transition marker gene expression (CDH2, SNAI1, ZEB1).
- GADD45B, CTGF, and JUNB were identified as differentially regulated genes associated with Smad3-EPSM-induced cell motility and invasiveness.
Conclusions:
- Inhibition of Smad3 linker phosphorylation may promote cancer cell motility and invasiveness.
- Upregulation of GADD45B, CTGF, and JUNB is implicated in this process across various cancers.
Related Concept Videos
Mutation, Gene Flow, and Genetic Drift
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Spontaneous and Induced Mutations
Mutations
Phase Transitions
Viral Mutations

